David Nutt, a psychiatrist and neuroscientist from Downing College, Cambridge, dives deep into the complexities of illicit drugs. He discusses the misalignment between drug regulation and actual harm, contrasting traditional substances like alcohol and cocaine with psychedelics, which have lower risks and therapeutic potential. Nutt explores the promise of psychedelics like MDMA and psilocybin for mental health treatment and the political hurdles inhibiting research. His insights shed light on addiction, the opioid crisis, and the pressing need for reevaluated drug policies.
01:38:44
forum Ask episode
web_stories AI Snips
view_agenda Chapters
menu_book Books
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
Early Brain Interest
David Nutt's early interest in the brain stemmed from realizing thinking originates there.
This led him to study neurology, then psychiatry, to understand the brain's complexity.
question_answer ANECDOTE
First Patient Encounter
Nutt's first psychiatric patient had olfactory hallucinations, smelling fish.
This sparked his interest in the link between temporal lobe disorders, consciousness, and smell.
insights INSIGHT
Ecstasy Harms
Nutt found that ecstasy harms stem from dehydration and hyperthermia, not the drug itself.
Policy changes like free water and chill-out rooms significantly reduced ecstasy-related deaths.
Get the Snipd Podcast app to discover more snips from this episode
Science Reveals How Meditation Changes Your Mind, Brain, and Body
Richard J. Davidson
Daniel Goleman
In 'Altered Traits,' Daniel Goleman and Richard J. Davidson delve into the scientific research behind meditation, highlighting its ability to alter personality traits and benefit both mind and body. The book distinguishes between 'altered states' of consciousness during meditation and 'altered traits,' which are lasting psychological changes. It discusses various levels of meditation practice, from beginner to 'Olympic-level' meditators, and presents findings from over 6,000 scientific studies, focusing on those that meet high methodological standards. The authors explain how meditation can reduce stress, improve emotional health, enhance focus, and even change brain pathways, leading to more equanimity and compassion[1][4][5].
The corner
a year in the life of an inner-city neighbourhood
Ed Burns
Edward Burns
David Simon
The book follows the lives of individuals, particularly the McCullough family, living on the corner of Fayette Street and Monroe Street in West Baltimore. It examines the sinister realities of inner cities, the failures of law enforcement policies, moral crusades, and the welfare system, and highlights the poignant scenes of hope, caring, and love amidst the drug culture. Simon and Burns spent over a year interviewing and following the people of the neighborhood, providing a detailed and non-judgmental portrayal of a community in deep decline.
Brain and Mind Made Simple
David Nutt
Brain and Mind Made Simple by David J. Nutt provides an accessible explanation of how the brain works and how alterations in brain function can lead to mental and neurological issues. The book is designed for both students and the general public, offering insights into the complexities of the human brain and mind through examples and patient histories.
David Nutt is a psychiatrist and a neuroscientist at Downing College, Cambridge. His research focuses on illicit drugs—their harm, classification, and potential for therapeutic use in psychiatry. In this episode, David discusses his framework for assessing the potential harm caused by common recreational drugs and explains how they are regulated, which is oftentimes misaligned with actual risk. He describes in detail the neurobiology, mechanisms of action, and addiction potential of alcohol, opiates, cocaine, and methamphetamine and contrasts those with psychedelics, which have been given a similar regulatory classification despite their relatively low risk of harm and their numerous potential therapeutic uses. Additionally, David explains the promise of psychedelics like ketamine, MDMA, and psilocybin for treating drug addiction and depression and discusses how political pressures have created roadblocks to future necessary research. We discuss:
David’s early interest in the brain and experience in psychiatry [2:45];
David’s brief work on government drug policy in the UK [10:15];
A scale for rating the relative harm of certain drugs [13:45];
The contrast in regulation between cannabis vs. alcohol and why research on potential benefits of cannabis is lacking [19:15];
The opiate crisis and rise of fentanyl: the cause and potential solution [25:00];
The science of addiction and the potential use of psychedelics for treating drug addiction [35:00];
Cocaine: mechanisms of action and risks [41:45];
Methamphetamine and crystal meth: mechanisms of action and neurotoxicity [48:15];
How psychedelics came to be classified as schedule I drugs despite their numerous therapeutic uses [52:45];
The history of MDMA and the bad science and political forces leading to its demonization [1:08:45];
History of ketamine, medical use of esketamine, and the waning effects of psychedelics with increasing usage [1:13:30];
Psilocybin for depression: David’s promising research and the roadblocks to more robust experiments [1:20:15];More.
The Peter Attia Drive 
